﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Shahrekord University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Herbmed Pharmacology</JournalTitle>
      <Issn>2345-5004</Issn>
      <Volume>11</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2022</Year>
        <Month>10</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Phytochemical profile, anti-glycation effect, and advanced glycation end-products protein cross-link breaking ability of Sclerocarya birrea stem-bark crude extracts</ArticleTitle>
    <FirstPage>529</FirstPage>
    <LastPage>539</LastPage>
    <ELocationID EIdType="doi">10.34172/jhp.2022.61</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Oluwaseyefunmi Iyabo</FirstName>
        <LastName>Adeniran</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5975-7943</Identifier>
      </Author>
      <Author>
        <FirstName>Andrew Munyalo</FirstName>
        <LastName>Musyoki</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6577-6155</Identifier>
      </Author>
      <Author>
        <FirstName>Lesibana Samuel</FirstName>
        <LastName>Sethoga</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0472-6549</Identifier>
      </Author>
      <Author>
        <FirstName>Motetelo Alfred</FirstName>
        <LastName>Mogale</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6989-7520</Identifier>
      </Author>
      <Author>
        <FirstName>Sechene Stanley</FirstName>
        <LastName>Gololo</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8059-1941</Identifier>
      </Author>
      <Author>
        <FirstName>Leshweni Jeremia</FirstName>
        <LastName>Shai</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4799-7437</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jhp.2022.61</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>04</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>07</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Sclerocarya birrea stem-bark is widely used for the treatment of many medical conditions. Advanced glycation end-products (AGEs) are implicated in the pathogenesis of vascular complications of diabetes mellitus. The study, other than phytochemical composition, evaluated the anti-glycation and AGEs-protein cross-link breaking effects of S. birrea stem-bark extracts. Methods: Different S. birrea extracts and aminoguanidine (used as control) were incubated with bovine serum albumin (BSA) and glucose/fructose at 37oC for 40 days. Amounts of fluorescent AGEs (FAGEs) and immunogenic AGEs formed were determined. Anti-glycation activity percentage of each extract and aminoguanidine was calculated. Their AGEs-protein cross-link breaking abilities were also assessed. Standard techniques were employed for phytochemical screening. Volatile compounds were identified by means of gas chromatography mass spectrometry (GC-MS). Results: S. birrea stem-bark n-hexane extract was statistically more effective than aminoguanidine against the formation of total immunogenic AGEs (P&lt;0.05). For FAGEs, ethyl acetate, methanol, and water extracts exerted significantly higher anti-glycation effects than aminoguanidine (P&lt;0.001). Methanol extract exhibited the highest anti-glycation effect with an average IC50 value of 0.142 mg/mL against FAGEs. All extracts were effective in releasing BSA from the preformed collagen-AGEs-BSA cross-links. GC-MS enabled the identification of many biologically important compounds, including campesterol, stigmasterol, and 1-heptatricontanol. Conclusion: S. birrea stem-bark has a potential for usage in the management of complications in uncontrolled glucose metabolism.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Anti-glycation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Medicinal plant</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Phytochemistry</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetic vascular complications</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Protein glycation</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>